| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/19/2007 | CA2625219A1 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 04/19/2007 | CA2624307A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 04/19/2007 | CA2623759A1 Pyridopyrimidinone inhibitors of pim 1 and/or pim-3 |
| 04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | CA2622755A1 Mek inhibitors and methods of their use |
| 04/19/2007 | CA2621038A1 Triarylcarboxylic acid derivative |
| 04/18/2007 | EP1775295A1 Vanilloid receptor ligands and their use in treatments |
| 04/18/2007 | EP1773828A1 Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 04/18/2007 | EP1773824A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 04/18/2007 | EP1773820A1 Hair growth promoting agents |
| 04/18/2007 | EP1773817A1 Substituted aryl-amine derivatives and methods of use |
| 04/18/2007 | EP1773798A1 Recovery of optically active epoxy alcohols |
| 04/18/2007 | EP1773797A2 Aromatic compounds |
| 04/18/2007 | EP1773786A2 Five-membered heterocycles useful as serine protease inhibitors |
| 04/18/2007 | EP1773781A2 Indazoles useful in treating cardiovascular diseases |
| 04/18/2007 | EP1773771A2 Compounds and methods for treatment of thrombosis |
| 04/18/2007 | EP1773770A1 Indole-2-carboxamidine derivatives as nmda receptor antagonists |
| 04/18/2007 | EP1773768A2 Pyrrole derivatives as pharmaceutical agents |
| 04/18/2007 | EP1773763A1 Lysine based compounds |
| 04/18/2007 | EP1773756A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/18/2007 | EP1773337A2 Modulators of nuclear receptors |
| 04/18/2007 | EP1553949B1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 04/18/2007 | EP1483243B1 Preparation of n1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | EP1265890B1 Stereoselective synthesis of nucleoside analogues |
| 04/18/2007 | EP1036066B1 Substituted pyrimidine and pyridine herbicides |
| 04/18/2007 | CN1950393A Novel inhibitors of hepatitis c virus ns3 protease |
| 04/18/2007 | CN1950364A Processes and intermediates for the preparation of aspartic acetal caspase inhibitors |
| 04/18/2007 | CN1950363A Process for preparing N-aryl-piperazine derivatives |
| 04/18/2007 | CN1950362A Process for the preparation of tryptase inhibitors |
| 04/18/2007 | CN1950361A Pyrrole or imidazole amides for treating obesity |
| 04/18/2007 | CN1950356A Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 04/18/2007 | CN1950351A 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 04/18/2007 | CN1950345A Morpholinylanilinoquinazoline derivatives for use as antiviral agents |
| 04/18/2007 | CN1950343A Basic amine compound and use thereof |
| 04/18/2007 | CN1950341A Naphthalimide derivatives for the treatment of cancer |
| 04/18/2007 | CN1950340A LXR receptor modulators |
| 04/18/2007 | CN1950081A Arylalkylamino-substituted quinazoline analogues |
| 04/18/2007 | CN1949966A Quinoxalin-2-one derivatives, crop protection agents comprising the same and method for production and use therof |
| 04/18/2007 | CN1310909C Novel heteroaryl derivatives, their prepn. and use |
| 04/18/2007 | CN1310908C Rapamycin 29-enols |
| 04/18/2007 | CN1310900C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same |
| 04/18/2007 | CN1310890C Isoquinoline derivatives |
| 04/17/2007 | US7205417 Spiro compounds |
| 04/17/2007 | US7205410 Heterocyclic amines used as antiemetics for prophylaxis of irritable bowel syndrome constipation, diarrhea, dyspepsia, nausea or vomiting |
| 04/17/2007 | US7205409 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomoderators |
| 04/17/2007 | US7205408 Therapy for bacteria infections in mammals |
| 04/17/2007 | US7205333 Therapy for influenza virus; inhaler |
| 04/17/2007 | US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide |
| 04/17/2007 | US7205328 Aids viricide |
| 04/17/2007 | US7205320 Such as 3-[3-(4-chlorophenyl)prop-1-yloxy]-4-methoxy-N-(3-pyridylmethyl)diphenylamine; reduced emetic side effect; neurological syndromes |
| 04/17/2007 | US7205318 Inhibitors of trypsin-like serine protease enzymes; for use as anticoagulant agents for therapy of thromboembolic disorders |
| 04/17/2007 | US7205317 Pain management |
| 04/17/2007 | US7205316 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 04/17/2007 | US7205315 Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases |
| 04/17/2007 | US7205310 inflammatory conditions such as multiple sclerosis |
| 04/17/2007 | US7205309 Obesity therapy; administering orlistat |
| 04/17/2007 | US7205307 Pyrimidines as novel openers of potassium ion channels |
| 04/17/2007 | US7205305 Inhibitors of p38 |
| 04/17/2007 | US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis |
| 04/17/2007 | US7205301 Microbiocidal N-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives |
| 04/17/2007 | US7205298 Substituted triazine kinase inhibitors |
| 04/17/2007 | US7205297 Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| 04/17/2007 | US7205295 such as 4-(4-tert-Butyl-benzyl)-6-(4-oxo-2-thioxo-thiazolidin-5-ylidenemethyl)-4H-1,4-benzoxazin-3-one; phosphoinositide-3-kinases (PI3Ks); for treatment/prevention of inflammatory diseases, cardiovascular diseases, and cancers |
| 04/17/2007 | US7205292 Piperidines containing a lactam ring and a quinolinone, benzimidazolone, quinazolinone or benzodiazepinone group, e.g. N-[3R,7R)-1-(Cyclopropylmethyl)-2-oxo-7-phenylazepan-3-yl]-4-(2-oxo-1,4-dihydroquinazolin-3 (2H-yl)piperidine-1-carboxamide; treating headaches, migraine headaches and cluster headaches |
| 04/17/2007 | CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists |
| 04/17/2007 | CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors |
| 04/17/2007 | CA2350073C Ccr5 modulators |
| 04/17/2007 | CA2299300C Arylpyridazinones as prostaglandin endoperoxide h synthase bisoynthesis inhibitors |
| 04/17/2007 | CA2203592C Process for the preparation of arylamides of heteroaromatic carboxylic acids |
| 04/17/2007 | CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 04/17/2007 | CA2141589C Antiretroviral enantiomeric nucleotide analogs |
| 04/12/2007 | WO2007041514A2 Process for selectively extracting procyanidins |
| 04/12/2007 | WO2007041324A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | WO2007041270A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | WO2007040682A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/12/2007 | WO2007040681A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/12/2007 | WO2007040440A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease |
| 04/12/2007 | WO2007040231A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | WO2007040208A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | WO2007040166A1 Novel fused pyrrole derivative |
| 04/12/2007 | WO2007040078A1 Quinophthalone compound |
| 04/12/2007 | WO2007039884A1 3 -azabicyclooctane derivatives as muscarinic receptor antagonists |
| 04/12/2007 | WO2007039782A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors |
| 04/12/2007 | WO2007039220A1 Novel quinoline compounds capable of binding at the cb2 receptor |
| 04/12/2007 | WO2007039170A1 Antagonists of topoisomerase activity and their use in inhibiting pathological conditions |
| 04/12/2007 | WO2007017135A3 Process for the preparation of olmesartan medoxomil |
| 04/12/2007 | WO2007016292A3 Heterocyclic amides as biofilm modulators |
| 04/12/2007 | WO2006134163A3 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 04/12/2007 | US20070083045 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 04/12/2007 | US20070082921 Quinazoline derivatives as antitumor agents |
| 04/12/2007 | US20070082912 Pyrrole compounds for the treatment of prostaglandine mediated diseases |
| 04/12/2007 | US20070082906 1-(1-{4-[3-(1,3-oxazol- 2-yl)-6-phenyl-1,2,4- triazin-5- yl]benzyl}piperidin-4- yl)-1,3-dihydro-2H- benzimidazol-2-one; inhibit activity of a serine, threonine protein kinase; hyperproliferative disorders, restenosis, inflammation, autoimmune diseases, allergy, asthma |
| 04/12/2007 | US20070082899 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/12/2007 | US20070082896 4-{[3,5-Bis(trifluoromethyl)benzyl]-[5-(4-carboxybutoxy)pyrimidin-2-yl]}amino-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester; cholesteryl ester transfer protein (CETP) inhibitors; increasing HDL cholesterol; lowering LDL cholesterol; arteriosclerosis, hyperlipidemia |
| 04/12/2007 | US20070082894 Pyrazine-based tubulin inhibitors |
| 04/12/2007 | US20070082883 HIV protease inhibitors |
| 04/12/2007 | CA2851103A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | CA2624875A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |